Axon Plunges 17.5% to Two-Year Low as Q3 Miss and Guidance Cut Hit Dedrone Delays
AXON is trading near its 52-week low of $308.11 (2.0% above the low) on elevated volume (2.6× avg).
Summary
Axon missed on both lines and cut full-year revenue guidance, and the stock is down 17.5% Friday to its lowest level since August 2024 — the biggest decliner on the S&P 500. The culprit is Dedrone: three large federal drone-detection deployments may not happen this year, projects that were expected to bring $130M of revenue and $200M in bookings in the second half. Management blamed slower federal procurement around funding and election cycles. FY2027 guidance came in light too — adjusted EBITDA of $924M-$929M and revenue of $3.61B-$3.63B versus $949M and $3.71B expected. Craig Hallum downgraded to Hold with a $390 target, flagging weakness in Taser and body cams as well. The company is also putting another $1.2B into Skydio, lifting its stake to roughly 37% and making it exclusive U.S. and Canada distributor — a bet that further concentrates exposure to one drone player.
At the time of this announcement, AXON was trading at $314.22 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $25.5B. The 52-week trading range was $308.11 to $665.07. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Seeking Alpha.